Centers for Disease Control and Prevention Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
Vaccination considerations for persons with underlying medication conditions When vaccine is limited, who should get vaccinated first? Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States

Interim considerations for COVID-19 vaccination of healthcare personnel and long-term care facility residents.

7
أضرار لقاح كورونا بين الحقائق والشائعات
Centers for Disease Control and Prevention
تعرَّف على الحقائق بخصوص لقاحات كوفيد 19
Morbidity and Mortality Weekly Report
ما هي الأعراض الجانبية من لقاح كورونا
COVID-19 vaccines vs variants — Determining how much immunity is enough
Phased allocation of COVID-19 vaccines Centers for Disease Control and Prevention
Centers for Disease Control and Prevention COVID-19 vaccine: Frequently asked questions

V-safe after vaccination health checker.

8
اضرار لقاح فايزر
Centers for Disease Control and Prevention
الآثار الجانبية الأكثر شيوعا للقاحات فايزر وأسترازينيكا
Centers for Disease Control and Prevention
أضرار لقاح كورونا بين الحقائق والشائعات
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants